HM
Howard Marks (Oaktree Capital) disclosed new in INDIVIOR PHARMACEUTICALS INC
Howard Marks (Oaktree Capital) filed a 13F change in INDIVIOR PHARMACEUTICALS INC (45579U109) on 2026-05-20, covering period end 2026-03-31.
Action
New
Capital
$212,875,428 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.